Bachrodt Amy bought MAZE
December 30, 2025 · Form 4 insider transaction
Bachrodt Amy bought 2,395 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $25.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,395
Price
$10.42
Total value
$25.0K
InsiderBachrodt Amy
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 30, 2025
Filing dateDecember 31, 2025
Shares owned after15,360
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.